Functionalization of nanoparticles with targeting ligands

GC Gil Covarrubias
AC Anthony Cha
AR Abdelrahman Rahmy
ML Morgan Lorkowski
VP Vindya Perera
BE Bernadette O. Erokwu
CF Chris Flask
PP Pubudu M. Peiris
WS William P. Schiemann
EK Efstathios Karathanasis
request Request a Protocol
ask Ask a question
Favorite

Functionalization of nanoparticles with vascular targeting ligands was accomplished via a sulfo-SMCC crosslinker. The nanoparticle composites, SPIO-NH2 and NC-NH2, had terminal amine groups that are readily available for conjugation with available thiol groups on the cysteine end of the targeting ligands. Here, P-selectin-targeting peptide CDAEWVDVS and fibrin-targeting peptide CREKA were used. Briefly, sulfo-SMCC contains two functional terminal groups on contralateral sides; an amine-reactive N-hydroxysuccinimide (NHS ester) and a sulfhydryl-reactive maleimide group. First, sulfo-SMCC in a 2-molar excess to available amine groups on the SPIO-NH2 solution and allowed to react for 30 minutes while shaking. Next, a 2:3 molar excess of sulfo-SMCC to targeting ligand was added and allowed to react for an additional 2 hours while shaking. The functionalized product was dialyzed against PBS using a 100,000 Da MW cut-off dialysis bag to remove excess peptide and crosslinker. For dual-ligand functionalization equal molar peptides were added with the overall molar excess to sulfo-SMCC still at a 2:3 molar ratio (2-moles sulfo-SMCC:1.5 moles fibrin-targeting peptide:1.5 moles P-selectin targeting peptide).

Bio-Rad DC protein assay was used to quantify the total number of conjugated peptides. Here, 200 μL of Bio-Rad dye solution (1 to 2 parts Bio-Rad dye and water) was added to an 800 μL solution of 10 mg/mL particles and vortexed. The absorbance of the sample was obtained at 595 nm after incubating the sample for 15 minutes. The absorbance value was compared to a standard curve, which was obtained by measuring the known absorbance of known concentrations of CREKA, P-selectin peptide or both.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A